Original filing text · Part I

Item 11 — Quantitative and Qualitative Disclosures About Market Risk

Genmab A/s · 20-F · FY 2025 · Period ended Dec 31, 2025

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

For qualitative and quantitative disclosures about market risks including foreign currency risk, interest rate risk, and credit risk, see Note 4.2 to our Audited Financial Statements included in our Annual Report 2025.